Rutgers, The State University Of New Jersey Patent Portfolio Statistics

tip_user1

Rutgers, The State University Of New Jersey

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Rutgers, The State University Of New Jersey look like?

Assignee Art Units
Total Applications: 1,484 1,932,938
Granted Patents: 1,021 1,051,373
Grant Index 78.42% ↑ 68.43%
Abandoned/Rejected Applications: 281 (21.58%) 485,060 (31.57%)
In-Process Applications: 180 396,505
Average Grant Time: 3.0 Years ↑ 2.76 Years
Average Office Actions: 1.82 ↑ 1.65

Which Technology Area Rutgers, The State University Of New Jersey is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
Opap Parked GAU 47
1645 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 45
1661 Plants 37
1652 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes 33
1618 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs 31

How many patents are Rutgers, The State University Of New Jersey filing every year?

Year Total Applications Predicted
2022 0* 396
2021 43* 409
2020 55 369
2019 71 71
2018 76 –
2017 66 –
2016 67 –
2015 67 –
2014 111 –
2013 90 –

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Rutgers, The State University Of New Jersey in USPTO?

Publication number: US20220184125A1
Application number: 17/551,006

Abstract:
Chimeric antigen receptors (CARs) including an scFv binding to coronavirus spike protein (S309 scFv), nucleic acids encoding the CARs, vectors including nucleic acids encoding the CARs, and cells expressing the CARs are provided. Methods of treating a subject with coronavirus are also provided, including administering to the subject a modified immune cell expressing a disclosed CAR.

Publication date: 2022-06-16
Applicant: Rutgers, The State University Of New Jersey
Inventors: Badeti Saiaditya

Publication number: US20220088271A1
Application number: 17/540,856

Abstract:
The present invention is a method for producing allograft tissue by applying an antimicrobial solution to allograft tissue. The antimicrobial solution exhibits antimicrobial activity to make allograft resistant to microbial organisms, such as a bacterium.

Publication date: 2022-03-24
Applicant: Rutgers, The State University Of New Jersey
Inventors: Lin S Sheldon

Publication number: US20220064715A1
Application number: 17/527,576

Abstract:
The present invention relates to novel primers and sloppy molecular beacon and molecular beacon probes for amplifying segments from different genes in Mycobacterium tuberculosis for identifying the presence of M.tb DNA and/or resistance to anti-tuberculosis drugs.

Publication date: 2022-03-03
Applicant: Rutgers, The State University Of New Jersey
Inventors: Alland David

How are Rutgers, The State University Of New Jersey’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/551,006 S309 Chimeric Antigen Receptors And Methods Of Use – OPAP Central, Docket
17/540,856 Methods For Preparing Tissue Grafts With Antimicrobial Properties Docketed New Case – Ready for Examination OPAP Central, Docket
17/527,576 Polymerase Chain Reaction Primers And Probes For Mycobacterium Tuberculosis Docketed New Case – Ready for Examination OPAP Central, Docket
17/595,341 Methods And Devices For Thickness-Limited Electrospray Additive Manufacturing Docketed New Case – Ready for Examination OPAP Central, Docket
17/611,241 High Concentration Cell Packaging And Shipping Docketed New Case – Ready for Examination OPAP Central, Docket